期刊文献+

降压药对原发性高血压患者血压变异性影响研究 被引量:2

Effects of Anti-hypertensive Drugs on Blood Pressure Variability in Patients with Essential Hypertension
下载PDF
导出
摘要 目的比较缬沙坦、氨氯地平、美托洛尔3种降压药对原发性高血压患者血压变异性(BPV)的影响。方法湖北省大冶市中医院急诊科2010年1月-2013年6月收治的原发性高血压患者150例。随机分为缬沙坦组、氨氯地平组、美托洛尔组,每组各50例。动态血压监测(ABPM)收集血压和BPV数据。结果缬沙坦、氨氯地平可以显著降低大多数时段的BPV,缬沙坦降幅最明显。氨氯地平能降低日间舒张压BPV,优于其他药物。美托洛尔只能降低夜间BPV,对其余时段反而有升高作用。结论理想的降压方案需要关注BPV的影响。缬沙坦和氨氯地平能显著改善高血压患者的BPV。 Objectives To compare the effects of three anti-hypertensive drugs-vatsartan, amlodipine and meto- prolol on blood pressure variability (BPV) in patients with essential hypertension. Method 150 cases of pa- tients with essential hypertension received in the Emergency Department of Daye Hospital of Traditional Chi- nese Medicine from January 2010 to June 2013 were randomly divided into valsartan group, amlodipine group and metoprolol group with 50 cases in each group. Blood pressure and BPV data were collected through ambu- latory blood pressure monitoring (ABPM). Conclusion Valsartan and amlodipine significantly reduced BPV during most of the time and valsartan had the more obvious effect. Amlodipine better reduced daytime diastolic BPV of patients than other drugs. Metoprolol only reduced nighttime BPV and increased BPV during the rest of the time. Conclusion The ideal anti-hypertensive program need pay attention to the effect of BPV. Valsar- tan and amlodipine can significantly improve the BPV of patients with hypertension.
作者 陈小明
出处 《保健医学研究与实践》 2014年第1期49-51,共3页 Health Medicine Research and Practice
关键词 原发性高血压 降压药 血压变异性 临床对照研究 Essential hypertension Anti-hypertensive drugs Blood pressure variability Controlled clinical research
  • 相关文献

参考文献6

二级参考文献33

  • 1[1]Julius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[J].Lancet,2004,363:2022-2031.
  • 2[2]Messerli FH,Staessen JA.Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies[J].Hypertension,2006,48:359-361.
  • 3[3]Poole-Wilson PA,Lubsen J,Kirwan BA,et al.Effect of longacting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial):randomised controlled trial[J].Lancet,2004,364:849-857.
  • 4[4]The DREAM Trial Investigators.Effect of ramipril on the incidence of diabetes[J].N Engl J Med,2006,355.
  • 5[5]Jan A,Staess EN,Yan LI,et al.Blood pressure reduction and cardiovascular prevention:An update including the 2003-2004 Secondary prevention trials[J].Hypertens Res,2005,28:385-407.
  • 6[6]Blood pressure lowering treatment trialists' collaboration..effects of different blood-pressure-lowering regimens on major cardiovascular events:results of prospectively designed overviews of randomised trials[J].Lancet,2003,362:1527-1535.
  • 7Parati G, Ongaro G, Bilo G, et al. Non-invasive beat-to-beat blood pressure monitoring: new developments[J]. Blood Press Monit,2003,8(1) :31-36.
  • 8Ko Y, Park J H, Yang MH, et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke[J]. Stroke, 2010,41(1): 2512-2518.
  • 9Shintani Y, Kikuya M, Hara A, et al. Ambulatory blood pres- sure, blood pressure variability and the prevalence of carotid ar-tery alteration: the Ohasama study[J].JHypertens,2007,25(8): 1704-1710.
  • 10Bilo G, Giglio A, Styczkiewicz K, etal. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall[J]. J Hypertens, 2007,25 (10) : 2058-2066.

共引文献93

同被引文献18

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部